The Immunological Response of Salmonella typhi Protein Subunits (Outer Membrane Protein 36 kDa, Fimbriae 36 kDa, and Flagellin) as a Candidate for Oral Typhoid Vaccine

Author:

Widyastuti Helmy1,Santoso Sanarto2,Winarsih Sri3,Poeranto Sri4

Affiliation:

1. Doctoral program of Medical Science, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia. Department of Biology, Faculty of Mathematics and Natural Sciences, Hasanuddin University, Makassar, Indonesia.

2. Department of Microbiology, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.

3. Department of Pharmacy, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.

4. Department of Parasitology, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.

Abstract

Salmonella typhi infection leads to typhoid fever on a global scale, particularly in developing countries. The currently available vaccine has its drawbacks that sporadically render a concern. Thereby, a new proffered vaccine needs to be proposed, such as a vaccine from bacteria’s protein subunits. Vaccine subunits contain only the antigenic portion of the pathogen needed to elicit a protective immune response. This research aims to assess the immunogenic potential of the protein subunit of Salmonella typhi antigen in enhancing cellular and mucosal immune responses, so it can be applied as a candidate for the typhoid fever vaccine. The Salmonella typhi protein subunits used in this research are outer membrane protein (OMP), fimbriae, and flagellin. The efficacy of the vaccine was confirmed by its production of CD4+ and CD8+ T Cells for cellular immunity response, and its production of SIgA concentration for humoral immunity response. CD4+ and CD8+ T cell examination was performed by flow cytometry analysis, while SIgA confirmation was checked by ELISA method. The result shows that, based on its immunity responses, compared with OMP, fimbriae, and flagellin have more potential to be used as a vaccine candidate against typhoid fever.

Publisher

A and V Publications

Subject

Pharmacology (medical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3